A California lawmaker introduced a new bill that would force health insurers to disclose denial rates and explain those denials as anger grows over rising costs and uncovered medical care.
Medtronic plc (NYSE: MDT) today announced financial results for its third quarter (Q3) of fiscal year 2025 (FY25), which ended January 24, 2025.
The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.